Europe — EMA
Octreoscan (Indium In-111 Pentetreotide)
Indium In-111 pentetrapeptide, the active ingredient in Octreoscan, is a radiopharmaceutical presented as an injectable solution for intravenous use.
Request sourcing
What is Indium In-111 Pentetreotide?
Indium In-111 pentetrapeptide, the active ingredient in Octreoscan, is a radiopharmaceutical presented as an injectable solution for intravenous use. It binds to somatostatin receptors and is employed in diagnostic imaging to locate neuroendocrine tumors. GNH USA supplies Octreoscan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.
GNH USA supplies Octreoscan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.
What is Indium In-111 Pentetreotide used for?
Octreoscan is used primarily for imaging of neuro‑endocrine tumors that express somatostatin receptors. It helps : - Neuroendocrine tumor detection: Provides visual identification of tumor sites and metastases in somatostatin‑positive tumors. - Staging of tumor burden and extent of the disease in neuro endocrine cancers : t t t t. - t . - . - . - t . - . - . - . - . - . - . - . - . - . - . - . - t . - . - . - . - . - .\n- . - . - . - . - . - . - t. - . - . - . - . -. - . - . - . - . - . -. - . - . - . - - . - - . - - - - - - - - - - - - - - """
